The Signaling Effects of the US Food and Drug Administration Fast-Track Designation-Reference-Cited by-同舟云学术

The Signaling Effects of the US Food and Drug Administration Fast-Track Designation

Published:2016-05-26 Issue:4 Volume:38 Page:581-594
ISSN:0143-6570
Container-title:Managerial and Decision Economics
language:en
Short-container-title:Manage. Decis. Econ.

Author:

Miller Kathleen L.¹²,Nardinelli Clark¹,Pink George²,Reiter Kristin²

Affiliation:

1. Office of Planning, Office of the Commissioner; US Food and Drug Administration; Silver Spring MD USA

2. Department of Health Policy and Management, Gillings School of Global Public Health; University of North Carolina at Chapel Hill; Chapel Hill NC USA

Publisher

Wiley

Subject

Management of Technology and Innovation,Management Science and Operations Research,Strategy and Management,Business and International Management

Reference46 articles.

1. Information asymmetry, R&D, and insider gains;Aboody;The Journal of Finance,2002

2. Administration, U.S. Food and Drug 2015 Number of Fast-track Designations Granted http://www.accessdata.fda.gov/FDATrack/track?program=cder&id=CDER-RRDS-Number-of-Fast-Track-Designations-granted&fy=all

3. Administration, U.S. Food and Drug 2012 Fast Track, Accelerated Approval and Priority Review http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm

4. Wealth effect of drug withdrawals on firms and their competitors;Ahmed;Financial Management,2002

5. Prescription drug spending trends in the United States: looking beyond the turning point;Aitken;Health Affairs,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy;The European Journal of Health Economics;2023-11-14

2. Green financial regulation and shale gas resources management;Resources Policy;2023-08

3. The signaling effects of incremental information: Evidence from stacked US Food and Drug Administration designations;The Quarterly Review of Economics and Finance;2018-02

4. Do investors value the FDA orphan drug designation?;Orphanet Journal of Rare Diseases;2017-06-19